Polyvalent immunoglobulins: challenges and perspectives

doi:10.2450/2013.008s

Review

. 2013 Sep;11 Suppl 4(Suppl 4):s40-4.

doi: 10.2450/2013.008s.

Polyvalent immunoglobulins: challenges and perspectives

Isabella Quinti¹, Serelina Coluzzi², Federica Pulvirenti¹, Alessandro Prezzo¹, Gabriella Girelli³

Affiliations

¹ Department of Molecular Medicine, "Sapienza" University of Rome, Rome, Italy.
² Unit of Immunohaematology and Transfusion Medicine, "Sapienza" University of Rome, Rome, Italy.
³ Department of Molecular Medicine, "Sapienza" University of Rome, Rome, Italy Unit of Immunohaematology and Transfusion Medicine, "Sapienza" University of Rome, Rome, Italy.

PMID: 24333312
PMCID: PMC3853976
DOI: 10.2450/2013.008s

Review

Polyvalent immunoglobulins: challenges and perspectives

Isabella Quinti et al. Blood Transfus. 2013 Sep.

. 2013 Sep;11 Suppl 4(Suppl 4):s40-4.

doi: 10.2450/2013.008s.

Authors

Isabella Quinti¹, Serelina Coluzzi², Federica Pulvirenti¹, Alessandro Prezzo¹, Gabriella Girelli³

Affiliations

¹ Department of Molecular Medicine, "Sapienza" University of Rome, Rome, Italy.
² Unit of Immunohaematology and Transfusion Medicine, "Sapienza" University of Rome, Rome, Italy.
³ Department of Molecular Medicine, "Sapienza" University of Rome, Rome, Italy Unit of Immunohaematology and Transfusion Medicine, "Sapienza" University of Rome, Rome, Italy.

PMID: 24333312
PMCID: PMC3853976
DOI: 10.2450/2013.008s

No abstract available

PubMed Disclaimer

Figures

**Figure 1**
Algorithm for diagnosis in patients with hypogammaglobulinemias. **Legend** Ig: immunoglobulins; PID: Primary Immune Deficiencies; Ab: antibodies; PnPs23: 23-valent pneumococcal polysaccharides; FU: follow up; SD: standard deviation.

See this image and copyright information in PMC

Cited by

Health-Related Quality of Life in Patients with CVID Under Different Schedules of Immunoglobulin Administration: Prospective Multicenter Study.
Pulvirenti F, Cinetto F, Pecoraro A, Carrabba M, Crescenzi L, Neri R, Bonanni L, Fabio G, Agostini C, Spadaro G, Tabolli S, Farrugia A, Quinti I, Milito C. Pulvirenti F, et al. J Clin Immunol. 2019 Feb;39(2):159-170. doi: 10.1007/s10875-019-0592-5. Epub 2019 Jan 15. J Clin Immunol. 2019. PMID: 30644015 Free PMC article.
The growing importance of achieving national self-sufficiency in immunoglobulin in Italy. The emergence of a national imperative.
Farrugia A, Grazzini G, Quinti I, Candura F, Profili S, Liumbruno GM. Farrugia A, et al. Blood Transfus. 2019 Nov;17(6):449-458. doi: 10.2450/2019.0265-19. Epub 2019 Dec 11. Blood Transfus. 2019. PMID: 31846609 Free PMC article. Review.
Acupoint Autohemotherapy Attenuates DNCB-Induced Atopic Dermatitis and Activates Regulatory T Cells in BALB/c Mice.
Yan SH, Chen Y, Huang ZQ, Zhong WX, Wang XT, Tang YC, Zhao XY, Wu YS, Zhou C, Zhu W, Xiao W, Li X, Zhang DS. Yan SH, et al. J Inflamm Res. 2024 May 9;17:2839-2850. doi: 10.2147/JIR.S454325. eCollection 2024. J Inflamm Res. 2024. PMID: 38751687 Free PMC article.
Safety and tolerability of pooled human immune globulins after topical ophthalmic administration in New Zealand White rabbits.
Kaja S, Iqbal S, Pons Lopez B, Molina Zaragoza S, Mun C, Flavin MT, Jain S. Kaja S, et al. Cutan Ocul Toxicol. 2024 Sep;43(3):227-231. doi: 10.1080/15569527.2024.2381207. Epub 2024 Jul 31. Cutan Ocul Toxicol. 2024. PMID: 39086095
Plasma-derived medicinal products: demand and clinical use.
Grazzini G, Mannucci PM, Oleari F. Grazzini G, et al. Blood Transfus. 2013 Sep;11 Suppl 4(Suppl 4):s2-5. doi: 10.2450/2013.002s. Blood Transfus. 2013. PMID: 24333309 Free PMC article. No abstract available.

See all "Cited by" articles

References

1. Council of Europe. Human normal immunoglobulin for intravenous administration Monograph 01/2002:0918 European Pharmacopoeia. 4th ed. Strasbourg: Council of Europe Publishing; 2002. (4.02)
1. Ochsenbein AF, Fehr T, Lutz C, et al. Control of early viral and bacterial distribution and disease by natural antibodies. Science. 1999;286:2156–9. - PubMed
1. Kaveri SV. Intravenous immunoglobulin: exploiting the potential of natural antibodies. Autoimmun Rev. 2012;11:792–4. - PubMed
1. Durandy A, Kaveri SV, Kuijpers TW, et al. Intravenous immunoglobulins - understanding properties and mechanisms. Clin Exp Immunol. 2009;158(Suppl 1):2–13. - PMC - PubMed
1. Kaveri SV, Lacroix-Desmazes S, Bayry J. The anti-inflammatory IgG. N Engl J Med. 2008;359:307–9. - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- The Lens - Patent Citations Database

[1] Council of Europe. Human normal immunoglobulin for intravenous administration Monograph 01/2002:0918 European Pharmacopoeia. 4th ed. Strasbourg: Council of Europe Publishing; 2002. (4.02)

[2] Council of Europe. Human normal immunoglobulin for intravenous administration Monograph 01/2002:0918 European Pharmacopoeia. 4th ed. Strasbourg: Council of Europe Publishing; 2002. (4.02)

[3] Ochsenbein AF, Fehr T, Lutz C, et al. Control of early viral and bacterial distribution and disease by natural antibodies. Science. 1999;286:2156–9. - PubMed

[4] Ochsenbein AF, Fehr T, Lutz C, et al. Control of early viral and bacterial distribution and disease by natural antibodies. Science. 1999;286:2156–9. - PubMed

[5] Kaveri SV. Intravenous immunoglobulin: exploiting the potential of natural antibodies. Autoimmun Rev. 2012;11:792–4. - PubMed

[6] Kaveri SV. Intravenous immunoglobulin: exploiting the potential of natural antibodies. Autoimmun Rev. 2012;11:792–4. - PubMed

[7] Durandy A, Kaveri SV, Kuijpers TW, et al. Intravenous immunoglobulins - understanding properties and mechanisms. Clin Exp Immunol. 2009;158(Suppl 1):2–13. - PMC - PubMed

[8] Durandy A, Kaveri SV, Kuijpers TW, et al. Intravenous immunoglobulins - understanding properties and mechanisms. Clin Exp Immunol. 2009;158(Suppl 1):2–13. - PMC - PubMed

[9] Kaveri SV, Lacroix-Desmazes S, Bayry J. The anti-inflammatory IgG. N Engl J Med. 2008;359:307–9. - PubMed

[10] Kaveri SV, Lacroix-Desmazes S, Bayry J. The anti-inflammatory IgG. N Engl J Med. 2008;359:307–9. - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Polyvalent immunoglobulins: challenges and perspectives

Affiliations

Polyvalent immunoglobulins: challenges and perspectives

Authors

Affiliations

Figures

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources